W
WAVEMAN · COMPANY
SGHT · Sight Sciences, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

SGHT

Sight Sciences, Inc.
MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0001531177
FORM 144 · 12☆ WATCH
INSIDER NET · 180D
-$756.6K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
62
13F, latest reported quarter
REVENUE GROWTH
-3.1%
XBRL, annual
NET MARGIN
-49.7%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$756.6K over 180 days
-$379.6K over 90 days · -$194.9K of it by a 10%+ holder
below 58% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
62 funds added or opened last quarter
below 55% of Medical Devices
REVENUE
-3.1% year over year
below 78% of Medical Devices
MARGIN
-49.7% net margin
below 73% of Medical Devices
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$756.6K across 6 people in 180 days.
62 funds added or opened positions in the latest 13F quarter, of 115 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +117.6%
+117.6%12M
-17%+33%+83%+134%2025-092025-102025-122026-032026-052026-072026-09 2025-11-25 · HAYDEN JEREMY B. sold $362.4K2026-01-02 · Badawi Paul sold $188.4K2026-07-01 · Badawi Paul sold $155.5K2026-01-16 · Badawi Paul sold $148.0K2026-07-02 · Bauerlein Alison sold $129.6K2025-12-16 · Encrantz Staffan bought $116.0K2026-04-01 · Badawi Paul sold $108.2K2025-11-17 · Taylor Brenton sold $101.8K2026-04-02 · Bauerlein Alison sold $90.0K2026-01-06 · Badawi Paul sold $88.8K2026-01-05 · Bauerlein Alison sold $85.2K2025-10-01 · Badawi Paul sold $81.6K2026-01-05 · HAYDEN JEREMY B. sold $73.4K2026-01-06 · Bauerlein Alison sold $72.2K2026-07-06 · HAYDEN JEREMY B. sold $70.1K2026-06-10 · Encrantz Staffan bought $68.8K2025-10-02 · Bauerlein Alison sold $65.8K2026-05-18 · Bauerlein Alison sold $65.2K2026-04-06 · HAYDEN JEREMY B. sold $48.9K2026-01-16 · HAYDEN JEREMY B. sold $41.8K2026-07-06 · Badawi David sold $40.9K2026-07-02 · Rodberg James sold $37.0K2026-01-05 · Rodberg James sold $34.4K2026-01-16 · Badawi David sold $32.0K2025-10-03 · HAYDEN JEREMY B. sold $31.8K2026-04-02 · Badawi David sold $28.4K2026-01-06 · Badawi David sold $27.6K2026-04-06 · Rodberg James sold $25.7K2025-11-12 · HAYDEN JEREMY B. sold $25.2K2026-01-05 · Badawi David sold $23.9K2026-01-02 · Badawi David sold $21.7K2025-12-02 · Rodberg James sold $20.8K2025-10-03 · Badawi David sold $19.7K2026-01-16 · Rodberg James sold $17.3K2026-07-01 · Taylor Brenton sold $15.3K2026-01-06 · HAYDEN JEREMY B. sold $13.4K2026-04-01 · Taylor Brenton sold $10.6K2026-01-06 · Taylor Brenton sold $4.6K2026-01-06 · Rodberg James sold $4.4K2025-10-06 · Taylor Brenton sold $2.0K2026-09-01 · HAYDEN JEREMY B. filed to sell $110.0K2026-08-17 · HAYDEN JEREMY B. filed to sell $97.8K2026-08-14 · HAYDEN JEREMY B. filed to sell $395.9K2026-08-13 · HAYDEN JEREMY B. filed to sell $20.8K2026-08-12 · HAYDEN JEREMY B. filed to sell $133.3K2026-08-11 · HAYDEN JEREMY B. filed to sell $165.9K2026-07-06 · Badawi David filed to sell $40.9K2026-07-06 · HAYDEN JEREMY B. filed to sell $70.1K2026-07-02 · Bauerlein Alison filed to sell $129.5K2026-07-02 · Rodberg James filed to sell $37.0K2026-07-01 · Badawi Paul filed to sell $155.4K2026-07-01 · Taylor Brenton filed to sell $15.3K
INSIDER BUYINSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $756.6K sold by insiders over 180 days, 62 funds added last quarter, $1.4M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
TMOPENROKBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDX
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Sight Sciences, Inc. insiders sold a net $756.6K of stock across 128 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Badawi David
Chief Technology Officer
SELL
2026-07-06
7,418.0
$40.9K
HAYDEN JEREMY B.
Chief Legal Officer
SELL
2026-07-06
12,733.0
$70.1K
Bauerlein Alison
Chief Operating Officer
SELL
2026-07-02
24,184.0
$129.6K
Rodberg James
Chief Financial Officer
SELL
2026-07-02
6,902.0
$37.0K
Badawi Paul
President and CEO
SELL
2026-07-01
28,684.0
$155.5K
128 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 123 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Long Focus Capital Management, LLC
3,844,100.0 sh
$20.8M
BlackRock, Inc.
3,083,108.0 sh
$16.7M
Americana Partners, LLC
1,679,069.0 sh
$9.1M
Pathstone Holdings, LLC
1,678,980.0 sh
$9.1M
VANGUARD CAPITAL MANAGEMENT LLC
1,573,815.0 sh
$8.5M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
HAYDEN JEREMY B.
FILED 2026-09-01
$110.0K
HAYDEN JEREMY B.
FILED 2026-08-17
$97.8K
HAYDEN JEREMY B.
FILED 2026-08-14
$395.9K
HAYDEN JEREMY B.
FILED 2026-08-13
$20.8K
HAYDEN JEREMY B.
FILED 2026-08-12
$133.3K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Invesco Dorsey Wright SmallCap Momentum ETF
$846.9K POSITION · AS OF 2026-02-28
0.2%
Ultra-Small Company Market Fund
$209.4K POSITION · AS OF 2026-03-31
0.2%
SIIT SMALL CAP II FUND
$313.7K POSITION · AS OF 2026-02-28
0.1%
Zacks Small-Cap Core Fund
$36.5K POSITION · AS OF 2026-02-28
0.1%
Gabelli Global Mini Mites Fund
$8.7K POSITION · AS OF 2026-03-31
0.0%
U.S. Small Cap Equity Fund
$69.9K POSITION · AS OF 2026-03-31
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 15 registered trials, 2 still enrolling or running — a status change here is dated weeks before the press release
1
Phase 4
0 ACTIVE
14
Not applicable
2 ACTIVE
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$77.4M$79.9M$81.1M$71.3M
GROSS PROFIT$66.7M$68.3M$69.2M$59.0M
OPERATING INCOME$-37.1M$-50.5M$-57.3M$-84.0M
NET INCOME$-38.4M$-51.5M$-55.5M$-86.2M
EPS (DILUTED)-0.74-1.03-1.14-1.80
OPERATING CASH FLOW$-29.7M$-22.4M$-47.2M$-76.0M
CASH$92.0M$120.4M$138.1M$185.0M
LONG-TERM DEBT$40.3M$39.4M$31.7M$33.3M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →